(Q83288982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Epidemiology of valvular heart disease in the adult (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

1 reference

Bernard Iung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alec Vahanian

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

25 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Cardiology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

162-172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

Worldwide perspective of valve disease

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

The global burden of group A streptococcal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Intensity of murmurs correlates with severity of valvular regurgitation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Burden of valvular heart diseases: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Valvular heart disease in the community: a European experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Role of echocardiography in toxic heart valvulopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Incidence of acute rheumatic fever in the world: a systematic review of population-based studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Pathogenesis of acute rheumatic fever and rheumatic heart disease: evasive after half a century of clinical, epidemiological, and laboratory investigation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Status of rheumatic heart disease in rural Pakistan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Rheumatic heart disease in Asia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Epidemiology of rheumatic heart disease in black shcoolchildren of Soweto, Johannesburg

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Prevalence of rheumatic heart disease detected by echocardiographic screening.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Management of the elderly patient with aortic stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Familial aggregation of calcific aortic valve stenosis in the western part of France

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

New insights into the progression of aortic stenosis: implications for secondary prevention.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Rate of change in aortic valve area during a cardiac cycle can predict the rate of hemodynamic progression of aortic stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Mutations in NOTCH1 cause aortic valve disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

The prevalence of bicuspid aortic valve in newborns by echocardiographic screening.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Frequency of Bicuspid Aortic Valve in Young Male Conscripts by Echocardiogram

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Outcomes in adults with bicuspid aortic valves

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

A classification system for the bicuspid aortic valve from 304 surgical specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

The aortic root: structure, function, and surgical reconstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Functional anatomy of aortic regurgitation: accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Doppler echocardiographic assessment of progression of aortic regurgitation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Two-dimensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in patients with rheumatic mitral stenosis: implications for follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Maternal and perinatal outcome of pregnancies complicated by cardiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Mitral annular calcium causing mitral stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Natural history of asymptomatic mitral valve prolapse in the community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Prevalence and clinical outcome of mitral-valve prolapse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Mechanical properties of myxomatous mitral valves

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Heart Failure and Death After Myocardial Infarction in the Community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Prognosis of Carcinoid Heart Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Changing profile of infective endocarditis: results of a 1-year survey in France

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

A systematic review of population-based studies of infective endocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Infective endocarditis in Europe: lessons from the Euro heart survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Prophylaxis of infective endocarditis: current tendencies, continuing controversies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Percutaneous approaches to valvular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Temporal trends in percutaneous mitral commissurotomy over a 15-year period

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.202

Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of

31 March 2020

1 reference

12 December 2020

Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

1 reference

12 December 2020

Acute severe mitral regurgitation during first attacks of rheumatic fever: clinical spectrum, mechanisms and prognostic factors.

1 reference

12 December 2020

To operate or not on elderly patients with aortic stenosis: the decision and its consequences

1 reference

12 December 2020

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

1 reference

12 December 2020

10.1038/NRCARDIO.2010.202

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21263455%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference